BR112015027333A2 - composição aquosa, método para a obtenção de um benefício antitranspirante, método para a fabricação de uma composição antitranspirante aquosa e utilização de uma composição - Google Patents

composição aquosa, método para a obtenção de um benefício antitranspirante, método para a fabricação de uma composição antitranspirante aquosa e utilização de uma composição

Info

Publication number
BR112015027333A2
BR112015027333A2 BR112015027333A BR112015027333A BR112015027333A2 BR 112015027333 A2 BR112015027333 A2 BR 112015027333A2 BR 112015027333 A BR112015027333 A BR 112015027333A BR 112015027333 A BR112015027333 A BR 112015027333A BR 112015027333 A2 BR112015027333 A2 BR 112015027333A2
Authority
BR
Brazil
Prior art keywords
composition
antiperspirant
aqueous
obtaining
benefit
Prior art date
Application number
BR112015027333A
Other languages
English (en)
Other versions
BR112015027333B1 (pt
Inventor
Mohamed Anwar M Fawzy Karim
Ronald Franklin Kevin
Christopher Waterfield Philip
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50771269&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112015027333(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of BR112015027333A2 publication Critical patent/BR112015027333A2/pt
Publication of BR112015027333B1 publication Critical patent/BR112015027333B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/591—Mixtures of compounds not provided for by any of the codes A61K2800/592 - A61K2800/596

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

resumo “composição aquosa, método para a obtenção de um benefício antitranspirante, método para a fabricação de uma composição antitranspirante aquosa e utilização de uma composição” a presente invenção se refere a uma composição aquosa que compreende o sal de cloreto de alumínio básico, sal de cálcio hidrossolúvel, e amino ácido, caracterizada pelo fato de que o sal básico é o cloreto de alumínio de fórmula al2oh4.4cl1.6 para al2oh4.9cl1.1 e aos métodos para a produção dessas composições que possuem um desempenho antitranspirante intensificado.
BR112015027333-5A 2013-05-20 2014-05-20 Composição aquosa, método para a obtenção de um benefício antitranspirante, método para a fabricação de uma composição antitranspirante aquosa e usos de uma composição BR112015027333B1 (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP13168417.7 2013-05-20
EP13168417 2013-05-20
EP13168418.5 2013-05-20
EP13168418 2013-05-20
EP14168831 2014-05-19
EP14168831.7 2014-05-19
PCT/EP2014/060306 WO2014187802A1 (en) 2013-05-20 2014-05-20 Antiperspirant compositions

Publications (2)

Publication Number Publication Date
BR112015027333A2 true BR112015027333A2 (pt) 2017-09-12
BR112015027333B1 BR112015027333B1 (pt) 2022-04-26

Family

ID=50771269

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015027333-5A BR112015027333B1 (pt) 2013-05-20 2014-05-20 Composição aquosa, método para a obtenção de um benefício antitranspirante, método para a fabricação de uma composição antitranspirante aquosa e usos de uma composição

Country Status (12)

Country Link
US (1) US20160113850A1 (pt)
EP (3) EP4321147A3 (pt)
JP (1) JP2016519151A (pt)
CN (1) CN105228580B (pt)
AU (2) AU2014270473A1 (pt)
BR (1) BR112015027333B1 (pt)
CL (1) CL2015003352A1 (pt)
EA (1) EA038401B1 (pt)
ES (1) ES2658682T5 (pt)
MX (1) MX353277B (pt)
PH (1) PH12015502368B1 (pt)
WO (1) WO2014187802A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2017005488A (es) * 2014-10-27 2017-09-15 Unilever Nv Composiciones antitranspirantes anhidras.
EP3370831B1 (en) 2015-11-06 2022-03-23 Unilever IP Holdings B.V. Aerosol antiperspirant product
US10682293B2 (en) 2015-11-06 2020-06-16 Conopco, Inc. Aerosol antiperspirant product
AU2016349244B2 (en) 2015-11-06 2018-12-20 Unilever Global Ip Limited Antiperspirant compositions
WO2017118507A1 (en) 2016-01-07 2017-07-13 Unilever Plc Antiperspirant compositions
EP3482741B1 (en) * 2017-11-08 2020-07-15 Unilever PLC Antimicrobial antiperspirant compositions
AU2022423879A1 (en) 2021-12-22 2024-05-23 Unilever Global Ip Limited Cosmetic sweat management compositions
WO2024132396A1 (en) 2022-12-22 2024-06-27 Unilever Ip Holdings B.V. Antiperspirant aerosol composition
WO2024132397A1 (en) 2022-12-22 2024-06-27 Unilever Ip Holdings B.V. Antiperspirant aerosol composition

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4359456A (en) 1976-01-14 1982-11-16 Lever Brothers Company Antiperspirant activity of basic aluminum compounds
US4435382A (en) * 1980-07-14 1984-03-06 Bristol-Myers Company Anhydrous alcoholic antiperspirant suspension composition containing certain aluminum or aluminum/zirconium salt glycine complexes
US4818512A (en) * 1987-09-23 1989-04-04 Bristol-Myers Company Activated aluminum chlorhydroxide
EP0405598A2 (en) * 1989-06-30 1991-01-02 Dow Corning Corporation Process to control polymer distribution in antiperspirant salts
US6042816A (en) * 1998-08-19 2000-03-28 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
US5955065A (en) 1998-08-19 1999-09-21 The Gillette Company Antiperspirant compositions containing calcium salts
GB9822518D0 (en) * 1998-10-15 1998-12-09 Unilever Plc Antiperspirant compositions
GB9909440D0 (en) 1999-04-23 1999-06-23 Unilever Plc Package for dispensing a flowable cosmetic composition and product
DE19962878A1 (de) 1999-12-24 2001-06-28 Henkel Kgaa Antitranspirant-Zusammensetzung
BR8002322U (pt) 2000-10-16 2002-05-28 Filtrona Brasileira Ind E Com Recipiente armazenador e aplicador de desodorante lìquido
US6911195B2 (en) * 2002-12-16 2005-06-28 The Gillette Company Gel antiperspirant composition containing volatile linear silicone and calcium enhanced antiperspirant salt
CN1819904A (zh) 2003-07-08 2006-08-16 陶氏环球技术公司 为模制品进行表面标记的方法
US6942850B2 (en) 2003-08-15 2005-09-13 The Gillette Company Aqueous alcoholic antiperspirant composition containing calcium enhanced antiperspirant salt
FR2863490B1 (fr) 2003-12-16 2006-05-19 Oreal Composition deorante du type emulsion huile-dans-eau contenant un melange d'alkylpolyglycoside et d'alcool gras et un polyether polyurethane non-ionique associatif
EP1576946A1 (de) 2004-03-18 2005-09-21 Henkel Kommanditgesellschaft auf Aktien Verwendung von Inhibitoren Gram-positiver Kokken in Deodorantien und Antitranspirantien
WO2005105026A1 (de) * 2004-04-27 2005-11-10 Beiersdorf Ag Transparente kosmetische oder dermatologische formulierung
US7087220B2 (en) 2004-05-28 2006-08-08 Reheis, Inc. High pH antiperspirant compositions of enhanced efficacy
US8883129B2 (en) 2005-01-13 2014-11-11 The Procter & Gamble Company Enhanced efficacy antiperspirant active
US7704531B2 (en) * 2005-02-18 2010-04-27 Colgate-Palmolive Company Enhanced efficacy aluminum or aluminum-zirconium antiperspirant salt compositions containing calcium salt(s) and betaine
US20070020211A1 (en) * 2005-07-22 2007-01-25 Reheis, Inc. Betaine with Calcium and/or Strontium Antiperspirants
US20070148113A1 (en) 2005-12-05 2007-06-28 Cyril Lemoine Antiperspirant compositions comprising at least one dispersion of cationic colloidal silica particles, antiperspirant product, and cosmetic process for treating perspiration
US20070196303A1 (en) 2006-02-17 2007-08-23 Reheis, Inc. Stable buffered aluminum compositions having high hplc bands iii and iv containing calcium/strontium
DE102006020382A1 (de) 2006-04-28 2007-10-31 Henkel Kgaa Schnell trocknende kosmetische Emulsionen zur Roll-on-Applikation
US20070286830A1 (en) * 2006-06-13 2007-12-13 Reheis, Inc. Aluminum compositions of enhanced efficacy having high HPLC Bands III and IV
WO2008063188A2 (en) 2006-11-03 2008-05-29 Reheis, Inc. Betaine with calcium and/or strontium antiperspirants
US20080131354A1 (en) 2006-12-05 2008-06-05 Reheis, Inc. Polyaluminum calcium hydroxychlorides and methods of making the same
US7976828B2 (en) * 2007-02-02 2011-07-12 Colgate-Palmolive Company Antiperspirant/deodorant composition
US20090202599A1 (en) 2007-10-04 2009-08-13 Songtao Zhou Solid antiperspirant composition and method for making same
WO2009075678A1 (en) 2007-12-12 2009-06-18 Colgate-Palmolive Company Antiperspirant active compositions having sec chromatogram exhibiting high sec peak 4 intensity
US8388678B2 (en) 2007-12-12 2013-03-05 Boston Scientific Scimed, Inc. Medical devices having porous component for controlled diffusion
EP2191868A1 (de) * 2008-11-28 2010-06-02 Cognis IP Management GmbH Ethylenoxid-freie Antiperspirant/Desodorant-Zubereitungen
WO2011016807A1 (en) 2009-08-06 2011-02-10 Colgate-Palmolive Company Method of making an antiperspirant active composition having sec chromatogram exhibiting high sec peak 4 intensity
US20110038823A1 (en) 2009-08-13 2011-02-17 The Dial Corporation Antiperspirant emulsion products with improved efficacy and processes for making the same
US20110038902A1 (en) 2009-08-13 2011-02-17 The Dial Corporation Antiperspirant compositions and products and methods for manufacturing antiperspirant compositions and products
DE102010038358A1 (de) 2010-07-23 2012-01-26 Henkel Ag & Co. Kgaa Doppelsalz-haltige Antitranspirant-Roll-Ons
EP2635352B1 (en) 2010-11-02 2018-01-10 Colgate-Palmolive Company Antiperspirant active compositions and manufacture thereof
DE102011002863A1 (de) 2011-01-19 2012-07-19 Henkel Ag & Co. Kgaa Antitranspirant-Stifte mit verbesserter Langzeitstabilität
DE102011003331A1 (de) * 2011-01-28 2012-08-02 Henkel Ag & Co. Kgaa Hautnährende Antitranspirant-Zusammensetzungen
AU2011366870B2 (en) 2011-04-26 2014-10-30 Colgate-Palmolive Company Antiperspirant active compositions and manufacture thereof
WO2012148481A1 (en) 2011-04-26 2012-11-01 Colgate-Palmolive Company Compositions containing polyhydroxyoxoaluminum cations and manufacture thereof
DE102012224133A1 (de) * 2012-12-21 2014-06-26 Henkel Ag & Co. Kgaa Textil schonende Nonaerosol-Antitranspirantien mit Methansulfonsäure

Also Published As

Publication number Publication date
CL2015003352A1 (es) 2016-07-08
ES2658682T5 (es) 2021-10-26
PH12015502368A1 (en) 2016-02-22
EP2999452B1 (en) 2017-12-13
WO2014187802A1 (en) 2014-11-27
ES2658682T3 (es) 2018-03-12
BR112015027333B1 (pt) 2022-04-26
EP3295922A1 (en) 2018-03-21
PH12015502368B1 (en) 2016-02-22
EP2999452A1 (en) 2016-03-30
AU2017202102A1 (en) 2017-04-20
EP2999452B2 (en) 2021-01-20
EP4321147A3 (en) 2024-05-01
CN105228580B (zh) 2019-05-31
MX2015016068A (es) 2016-03-21
EA201591678A1 (ru) 2016-05-31
JP2016519151A (ja) 2016-06-30
AU2014270473A1 (en) 2015-10-29
MX353277B (es) 2018-01-05
EP3295922B1 (en) 2024-04-17
CN105228580A (zh) 2016-01-06
US20160113850A1 (en) 2016-04-28
EP4321147A2 (en) 2024-02-14
AU2017202102B2 (en) 2018-09-13
EA038401B1 (ru) 2021-08-23

Similar Documents

Publication Publication Date Title
BR112015027079A2 (pt) composição aquosa, método para a obtenção de um benefício antitranspirante, método para a fabricação de uma composição antitranspirante aquosa, sal antitranspirante e método para a obtenção de um benefício antitranspirante
BR112015027333A2 (pt) composição aquosa, método para a obtenção de um benefício antitranspirante, método para a fabricação de uma composição antitranspirante aquosa e utilização de uma composição
CL2019001066A1 (es) Sal de (s)-csa de s-ketamina, sal de (r)-csa de s-ketamina y procesos para la preparación de s-ketamina (divisional solicitud 201702854)
EA201890522A1 (ru) Способ получения противогрибковых соединений
BR112016024508A2 (pt) emulsão, processo para preparação de uma emulsão, e, uso de uma emulsão
EA201490458A1 (ru) Способ получения тернесита
AR097158A1 (es) Polimorfo de inhibidores de tirosina quinasa de bazo (syk)
EA201691648A1 (ru) Способ получения противогрибковых соединений
EA201691649A1 (ru) Способ получения противогрибковых соединений
BR112014014939A2 (pt) composição de tratamento de sementes
PL408377A1 (pl) Sposób wytwarzania grafenu płatkowego na drodze bezpośredniej eksfoliacji grafitu
TW201613603A (en) Pharmaceutical preparation
CY1119888T1 (el) Μεθοδος για την παρασκευη ξανθοχουμολης
BR112016027760A8 (pt) método de síntese de ph baixo de complexo de zinco-lisina
MX2018004033A (es) Composicion acuosa que contiene dantroleno.
CA2922375C (en) Alpha-tea salt forms: compositions and uses for treating disease
BR112019001447A2 (pt) método de produção para composto pirazol-amida
EA201891431A1 (ru) Способы получения замещенного 5,6-дигидро-6- фенилбензо[f]изохинолин-2-амина
BR112016018594B8 (pt) Método para produção do derivado de 2-aciliminopiridina
UA113988C2 (xx) Спосіб стабілізації бета-напівгідрату штукатурного гіпсу
BR112017004166A2 (pt) sal de derivado de cefalosporina, forma sólida cristalina do mesmo e método para produzir o mesmo
MY156402A (en) Hydraulic composition
EA201591449A1 (ru) Способы получения противораковых композиций
BR112015026759A2 (pt) síntese de inibidores bace
CY1120482T1 (el) Μεθοδος συνθεσης 3,4-διμεθοξυδικυκλο[4.2.0]οκτα-1,3,5-τριενο-7-καρβονιτριλιου και εφαρμογη στη συνθεση της ιβαμπραδινης και των αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξy

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: UNILEVER IP HOLDINGS B.V. (PB)

B350 Update of information on the portal [chapter 15.35 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/05/2014, OBSERVADAS AS CONDICOES LEGAIS.